$NKTX Nkarta, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Nkarta, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Nkarta, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Nkarta, Inc. for free.

CIK Number: 0001787400
IRS Number: 474515206
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NKTX
Company Address: 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO 94080
Phone number: 650-215-0385

Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.

Nkarta, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
HASTINGS PAUL JChief Executive Officer241,6000shares bought: 0 / shares sold: -17,000 STRONG SELLApr 01 20211 month ago
Mahmood NadirSee Remarks34,9880shares bought: 12,083 / shares sold: -9,000 BUYApr 02 20211 month ago
RA CAPITAL MANAGEMENT, LLCDirector260,8190shares bought: 6,173,162 / shares sold: 0 STRONG BUYApr 05 20211 month ago
Trager JamesChief Scientific Officer45,7220shares bought: 7,300 / shares sold: -10,000 SELLMay 05 20217 days ago

View all Nkarta, Inc. insiders.

Nkarta, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 05 2021NKTXNkarta, Inc.Trager JamesChief Scientific Of ...Option ExerciseM3.892,2508,75357,662
May 05 2021NKTXNkarta, Inc.Trager JamesChief Scientific Of ...SellS31.642,25071,19045,72248 K to 45.7 K (-4.69 %)
May 05 2021NKTXNkarta, Inc.Trager JamesChief Scientific Of ...BuyM3.892,2508,75347,97245.7 K to 48 K (+4.92 %)
May 05 2021NKTXNkarta, Inc.Trager JamesChief Scientific Of ...SellS31.641,35042,71445,72247.1 K to 45.7 K (-2.87 %)
Apr 05 2021NKTXNkarta, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorBuyJ32.90307,21410,107,3414,589,9994.3 M to 4.6 M (+7.17 %)
Apr 05 2021NKTXNkarta, Inc.RA CAPITAL MANAGEMENT, L.P.DirectorBuyJ32.90260,8198,580,945260,8190 to 260.8 K
Apr 02 2021NKTXNkarta, Inc.Mahmood NadirSee RemarksOption ExerciseM3.893,50013,61574,243
Apr 02 2021NKTXNkarta, Inc.Mahmood NadirSee RemarksSellS32.703,500114,45031,48835 K to 31.5 K (-10.00 %)
Apr 02 2021NKTXNkarta, Inc.Mahmood NadirSee RemarksBuyM3.893,50013,61534,98831.5 K to 35 K (+11.12 %)
Apr 01 2021NKTXNkarta, Inc.HASTINGS PAUL JChief Executive Off ...SellS32.213,130100,817236,061239.2 K to 236.1 K (-1.31 %)
Apr 01 2021NKTXNkarta, Inc.HASTINGS PAUL JChief Executive Off ...SellS31.242,40975,257239,191241.6 K to 239.2 K (-1.00 %)
Apr 01 2021NKTXNkarta, Inc.HASTINGS PAUL JChief Executive Off ...SellS30.2311,461346,466241,600253.1 K to 241.6 K (-4.53 %)
Feb 03 2021NKTXNkarta, Inc.Trager JamesChief Scientific Of ...Option ExerciseM18.002,80050,40079,600
Feb 03 2021NKTXNkarta, Inc.Trager JamesChief Scientific Of ...Option ExerciseM3.892,2508,75359,912
Feb 03 2021NKTXNkarta, Inc.Trager JamesChief Scientific Of ...SellS40.002,800112,00047,07249.9 K to 47.1 K (-5.61 %)

View all Nkarta, Inc. insider transactions.